ClinicalTrials.govpublic full text
Real World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center Osijek
inflammatory bowel diseases, crohn disease, colitis, ulcerative, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 869942
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.